We are a close-knit team inspired by the possibilities of delivering transformative technologies and breakthrough science to change the course of medicine. We value our people as our most important resource and are always looking for talented individuals who can make valuable contributions to our efforts. If you think you’d be a good fit, take a look at our current open positions.

Christina is a pioneer in the fields of synthetic biology and metabolic engineering, where she has over 20 years of experience. As Professor of Bioengineering and Chemical Engineering at Stanford University, her laboratory led the breakthrough research to engineer baker’s yeast to produce valuable plant-based medicines. Her innovative vision and accomplishments have garnered numerous awards, including the Chan-Zuckerberg Biohub Investigator, NIH Director’s Pioneer Award, Nature’s 10, World Technology Network Award in Biotechnology, and TR35 Award.

Christina earned her BS in Chemical Engineering from USC and her PhD in Chemical Engineering from UC Berkeley.

Christina Smolke, PhD

Co-Founder & CEO

Kristy has over 15 years of experience in the field of synthetic biology, focusing on yeast metabolic engineering for the production of small molecules. She did the founding work on the benzylisoquinoline alkaloid pathway during her graduate studies and gained valuable industry experience at Amyris and Lygos. Kristy is an expert in tool development, high-throughput screening, and host strain and heterologous pathway engineering. She believes that all plant-derived medicines will ultimately be produced using microbial fermentation technology.

Kristy earned her BS in Chemical Engineering from Texas A&M University and her PhD from the California Institute of Technology.

Kristy Hawkins, PhD

Co-Founder & CSO

Valerie joined Antheia in 2018 as Chief Financial Officer where she oversees Finance and Operations. Valerie comes to Antheia with over 20 years of finance experience across a number of industries including retail, software and manufacturing, and most recently served as Vice President of Finance for the biotechnology company, TerraVia, Inc.

Valerie received her MBA and BS degrees from Indiana University’s Kelley School of Business.

Valerie Minassian, MBA


Yihui leads fermentation research and development at Antheia. He has more than 20 years of hands-on microbial fermentation experience and 10+ years experience in industrial fermentation R&D. Prior to joining Antheia, Yihui built and managed fermentation teams at Codexis and Intrexon and led the development of robust and cost-effective microbial fermentation processes that were successfully transferred and scaled up to pilot scale and demonstration plants.

Yihui received his BA and MS in Fermentation Engineering from Jiangnan University in China and a Ph.D. in Agricultural and Biological Engineering from the University of Georgia.

Yihui Zhu, PhD

Head of Fermentation

Suzy leads our downstream chemistry processes in Antheia. She has 15+ years of experience in process development, including route development through synthetic chemistry, scale-up of small molecule APIs for GPCR targets under cGMP for Phase I-III trials. Before joined Antheia, Suzy led a full DSP team in Amyris where she successfully pivoted developments from biofuels hydrocarbon products to pharmaceutical intermediate, flavor, fragrance and nutraceutical products. Her leadership resulted in scaling 11 products and taking 5 products to commercial manufacturing.

Suzy received her BA in English and BS in Chemistry from San Diego State University.

Suzanne Sato

Head of Chemistry

Yen-Hsiang is leading strategy and business development at Antheia. Coming from a solid academic background, he has extensive research experience in synthetic biology, metabolic engineering and computational modeling. Yen-Hsiang devotes his efforts to driving technology innovations with commercial success. Before joining Anthiea, he was at McKinsey and then led AI healthcare strategy and product development in Tencent AI Lab.

Yen-Hsiang received his BS in Electrical Engineering from National Taiwan University and PhD in Bioengineering from Stanford University.

Yen-Hsiang Wang, PhD

Head of Strategy and BD